Simulation-Based Software Modeling of CAR T Cell Therapy Efficacy Against Solid Malignant Tumors
نویسندگان
چکیده
Genetically engineered T cells with Chimeric Antigen Receptors, CAR cells, are a revolutionary immunotherapy used to treat advanced blood cancers. The purpose of this experiment was model the destruction process tumor cell therapy using Complexity and Organized Behaviour Within Environmental Bounds (COBWEB), an agent-based simulation software. We designated parameter values for abiotic factors, agents (i.e. cells) general environment in our illustrate interactions between cytotoxic components, which described binding innate CD8+ or antigens. models were observe comparatively analyze rate solid by cells. developed circular island 60 ticks, representing days; then able infiltrate population monitored over 500 days. exhibited significantly powerful, efficient immune response against relative yet relapse occurred both albeit lesser extent However, further investigations required adequately simulate side effects realistically-limiting factors therapy. Similar comparative analyses may help measure compare potency compared standard, lack of, treatments.
منابع مشابه
Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities
Chimeric antigen receptor (CAR)-engineered T cells (CAR-T cells) have been shown to have unprecedented efficacy in B cell malignancies, most notably in B cell acute lymphoblastic leukemia (B-ALL) with up to a 90% complete remission rate using anti-CD19 CAR-T cells. However, CAR T-cell therapy for solid tumors currently is faced with numerous challenges such as physical barriers, the immunosuppr...
متن کاملEfficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ.
Adoptive T-cell therapy using chimeric antigen receptor-modified T cells (CAR-T therapy) has shown dramatic efficacy in patients with circulating lymphoma. However, eradication of solid tumors with CAR-T therapy has not been reported yet to be efficacious. In solid tumors, stroma destruction, due to MHC-restricted cross-presentation of tumor antigens to T cells, may be essential. However, CAR-T...
متن کاملEnhancing T cell persistence of CAR-redirected T cells in solid tumors
T cell persistence is likely to promote long-term antitumor effects after adoptive T cell transfer. We have recently shown that incorporation of the ICOS intracellular domain into chimeric antigen receptors (CARs) significantly increased Th17 cell persistence in vivo, compared to CARs with CD28 or 4-1BB intracellular domains [1]. Here, we hypothesized that CD4 and CD8 T cells require distinct c...
متن کاملClinical application of adoptive T cell therapy in solid tumors
As an emerging therapeutic approach, adoptive T cell therapy shown promise in advanced solid malignancies. The results obtained in patients with metastatic melanoma and kidney cancer are encouraging because of the visible clinical benefits and limited adverse effects. Recently, the genetically-modified T cells expressing specific T cell receptors or chimeric antigen receptors are just now enter...
متن کاملCAR T-cell Therapy of Hematologic Malignancies: An Update in Targeted Antigens
Immunotherapy with genetically engineered T-cells that express the chimeric antigen receptor (CAR) has raised hopes for the treatment of pediatric malignancies. Although CAR T-cell development is on a fast-moving pace and evolution, the context of exploring novel targetable antigens has been neglected. In this review study, we analyze the prominent hematologic antigens targeted by engineered T-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian journal of medicine
سال: 2023
ISSN: ['2564-0135', '2564-0127']
DOI: https://doi.org/10.33844/cjm.2023.6029